HALOPERIDOL

ANDA

HALOPERIDOL LACTATE | A076035 | TEVA PHARMACEUTICALS USA

1 strength0 unique patents0 unique exclusivities

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Apr 16, 2003	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 5MG BASE/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Aug 29, 2001

No patent or exclusivity listings for this strength.